MACHINE LEARNING & AI: A HIMSS EVENT
LAS VEGAS, NV - MARCH 5, 2018
Jennifer Esposito, MS, is worldwide general manager of Health and Life Sciences at Intel Corporation. In this role, Jennifer leads a worldwide team of technology leaders and subject matter experts to develop solutions that use information and communication technology to transform the health and life sciences industry. Jennifer has nearly 20 years of experience on the front lines of the medical imaging industry, global health systems and academic medicine. She worked as the senior director for the High Value Healthcare Collaborative—a consortium that included 20 leading U.S. health systems working to improve healthcare quality, outcomes, and costs of care, and to serve as a model for healthcare reform. She was also spent 13 years at GE Healthcare, in various roles, including leading the Interventional Radiology and Cardiology Service business, where her efforts focused on driving a digital transformation of the technical and customer support organization. She championed the development of a first of its kind industrial IoT platform, which enabled remote, proactive maintenance, reduced customer downtime and improved overall product reliability. Jennifer was awarded a patent for creating a system to track and optimize radiation dose in interventional radiology and cardiology, using machine and medical imaging data. Jennifer is a Steering Committee member of the Global Health Security Agenda (GHSA) Private Sector Roundtable (PSRT), and chairs the PSRT’s subcommittee on Technology and Analytics. Jennifer also co-chairs the Broadband Commission’s Working Group on Digital Health with the Novartis Foundation and sits on a number of other digital health and health security working groups and steering committees. Jennifer holds an MS in Epidemiology and Biostatistics from the Dartmouth Institute for Health Policy and Clinical Practice, and a BA from Dartmouth College. She is a member of the American Association of Physicists in Medicine and is a certified Six Sigma Black Belt.
Artificial Intelligence (AI) offers the promise to augment our human ability see patterns in data that we can’t see. That's important because some of these patterns contain secrets to some of the most perplexing problems in healthcare delivery and drug discovery. Jennifer Esposito, GM of Intel’s Health and Life Sciences Group, will share how new AI technology is being used today to help healthcare delivery organizations utilize historical data and build models and algorithms to predict future events. She’ll share examples of how healthcare organizations are already using AI to improve healthcare delivery through optimized clinical, operational and financial performance. Attendees will walk away with an understanding of the key trends, challenges, and practical guidance on how to get started with what many view as the next generation of computing.